RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Concurrent Chemoradiotherapy Tolerated in Recurrent HNSCC
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 31
SP 12
OP 12
DO 10.1177/155989771431009
UL http://mdc.sagepub.com/content/14/31/12.1.abstract
AB Due to the poor prognosis of recurrent head and neck squamous cell carcinoma (HNSCC), there is an imperative to identify a safe and tolerable therapy course. Despite the prevalence of combined radiotherapy and chemotherapy, an optimal therapeutic regimen has not been elucidated. This article discusses data from a multicenter prospective phase 2 study that looked at concurrent reirradiation and combined chemotherapy treatment for patients with HNSCC.